0 results available. Select is focused ,type to refine list, press Down to open the menu,
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company’...
The following section summarizes insights on Fate Therapeutics Inc's Quick Ratio:
We've identified the following companies as similar to Fate Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Quick Ratio in the risk category include:
A ratio used to assess a company's short-term liquidity.
Quick Ratio or acid-test or liquidity ratio measures the ability of a company to use its near cash or quick assets to extinguish or retire its current liabilities immediately. Quick Ratio is defined as:
(Cash & ST Investments
(+) Accounts Receivable)
(/) Current Liabilities
(=) Quick Ratio
Quick Ratio for Fate Therapeutics is calculated as follows:
(Cash & ST Investments [ 279.1 M ]
(+) Accounts Receivable [ 3.539 M ]
(/) Current Liabilities [ 38.522 M ]
(=) Quick Ratio [ 7.3x ]
The tables below summarizes the trend in Fate Therapeutics’s quick ratio over the last five years:
| Fiscal Year | Cash & ST Investments | Accounts Receivable | Current Liabilities | Quick Ratio |
|---|---|---|---|---|
| 2020-12-31 | 482.9 M | 5.515 M | 85.564 M | 5.7x |
| 2021-12-31 | 615.9 M | 8.676 M | 81.284 M | 7.7x |
| 2022-12-31 | 436.2 M | 38.48 M | 114.1 M | 4.2x |
| 2023-12-31 | 315.2 M | 1.826 M | 39.094 M | 8.1x |
| 2024-12-31 | 279.1 M | 3.539 M | 38.522 M | 7.3x |
The tables below summarizes the trend in Fate Therapeutics’s quick ratio over the last four quarters:
| Fiscal Year | Cash & ST Investments | Accounts Receivable | Current Liabilities | Quick Ratio |
|---|---|---|---|---|
| 2024-03-31 | 383.5 M | 858 T | 45.369 M | 8.5x |
| 2024-06-30 | 304.9 M | 1.048 M | 34.793 M | 8.8x |
| 2024-09-30 | 296.9 M | 4.127 M | 37.422 M | 8.0x |
| 2024-12-31 | 279.1 M | 3.539 M | 38.522 M | 7.3x |
Read more on Wikipedia: Quick Ratio
The chart above depicts the distribution of quick ratio for companies operating in the Healthcare sector in the Developed economic region. Over 2,330 companies were considered in this analysis, and 2,240 had meaningful values. The average quick ratio of companies in the sector is 3.3x with a standard deviation of 4.2x.
Fate Therapeutics Inc's Quick Ratio of 7.3x ranks in the 86.5% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,334 |
| Included Constituents | 2,240 |
| Min | 0.0x |
| Max | 23.2x |
| Median | 1.6x |
| Mean | 3.3x |
| Standard Deviation | 4.2x |
You can find companies with similar quick ratio using this stock screener.